Trial
NCT04254549
Rifaximin in Patients With Diabetic Gastroparesis
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Mayo Clinic
Collaborators
—
Condition
Crohn Disease
Intervention
Rifaximin
Why stopped
Sponsor discontinued placebo. Unable to meet enrollment goals.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-06-22